New York, NY, Point Roberts, WA - October 31, 2012 (Investorideas.com energy newswire) Investorideas.com, a leader in sector research for independent investors issues an energy stock trading alert for EFL Overseas Inc. (OTCBB: EFLO) following last week's news of its acquisition of additional rights and interests in the Liard basin gas field and facilities located in the Kotaneelee Area, Yukon Territory.

The stock was also featured in a recent Seeking Alpha article: An 'Off The Radar' Way To Play The Coming West Coast LNG Boom.

 SilverCrest Mines Inc. (TSX-V:SVL)(NYSE MKT:SVLC) (the "Company") is pleased to announce the completion of its underwritten prospectus offering in Canada announced on October 5, 2012 for gross proceeds of CAD$30 million, together with exercise of the over-allotment option in full for an additional $4.5 million, resulting in total gross proceeds of $34.5 million.

The Company plans to use the net proceeds of the offering to pay out and eliminate the remainder of the Company's gold hedge commitments and for general corporate purposes.

Pipestone, MN - October 29, 2012 (Investorideas.com renewable energy newswire) Juhl Wind, Inc. (OTCBB: JUHL), the Leader in Community Wind Power is pleased to announce that on Monday, October 29 th at 2:00 PM, the Obama Campaign will be holding a press conference at the Operations Headquarters of Juhl Wind, Inc. located at 996 190 th Avenue in Woodstock MN.

On Monday, October 29 th, former House Minority Leader Matthew Entenza will join Juhl Wind VP of Project Development Corey Juhl, VP of Operations Tyler Juhl and Juhl Wind President John Mitola to stress the importance of the extension of the Renewable Energy Federal Production Tax Credit (PTC) and President Obama's unwavering support of the clean energy sector.

SAN DIEGO - October 25, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, disclosed today that U.S. Patent number 8,288,172 was issued to the Company by the U.S. Patent and Trademark Office (USPTO) on October 16th, 2012. The patent entitled "Extracorporeal Removal of Microvesicular Particles," provides Aethlon Medical the exclusive right to remove immune suppressive microvesicular particles, which include but are not limited to exosomes from the circulation of treated patients. A therapy able to inhibit or reduce the presence of cancer-secreted exosomes would address a significant unmet medical need in the effort to combat cancer.